Exploration of the Oral Microbiome in Non-Ventilated Hospitalized Patients
Exploration of the Oral Microbiome in Non-Ventilated Hospitalized Patients
批准号:
10552239
负责人:
Kimberly P Rathbun
金额:
$0.25万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-12-17 至 2022-12-16
关键词:
AccountingAgeAge-YearsBacteriaBioinformaticsBiometryClinicalClinical DataComputerized Medical RecordDataData CollectionDental PlaqueDevelopmentDiscipline of NursingElderlyEnrollmentEnvironmentEpidemiologyEtiologyFloridaFutureGeneticGenomicsGoalsHealthHealth Care CostsHomeHospitalizationHospitalsHourIncidenceInterdisciplinary StudyInterventionKnowledgeLaboratoriesLaboratory ResearchLength of StayLungMeasuresMedical centerMentorshipMethodsMicrobeNosocomial pneumoniaNursesNursing HomesObservational StudyOralOral healthOrthopedicsOutcomeParticipantPathway interactionsPatient DischargePatient Self-ReportPatient-Focused OutcomesPatientsPneumoniaPrecision Medicine InitiativePrevention MeasuresPreventive carePreventive measureProblem SolvingReportingResearchResearch PersonnelRiskRisk FactorsSalivaryScientific Advances and AccomplishmentsScientistSpecimenStandardizationSystemTaxonomyTimeTrainingUnited States National Institutes of HealthUniversitiesVirulentWorkbasebeta diversitycosthealthcare-associated infectionsimprovedinnovationinsightlongitudinal designmicrobialmicrobial colonizationmicrobiome alterationmicrobiome analysismigrationmodifiable riskmortalitymultidisciplinaryneglectoral bacteriaoral careoral microbial communityoral microbiomepathogenprogramsprogressive careprospectiverecruitresidenceventilator-associated pneumonia
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Non-ventilator hospital acquired pneumonia (NV-HAP) is a prevalent healthcare-associated infection,
accounting for 60% of all healthcare-associated pneumonia cases. NV-HAP is associated with poor patient
outcomes including an increased hospital length of stay from 4.0 to 15.9 days, mortality rates of 13.1 to 30.0%,
and costs ranging from $28,000 to $40,000 per case. Multiple risk factors exist for NV-HAP development,
including poor oral health, oral microbiota, increased age, and residing in a nursing home. Although consistent
oral care is an effective preventive measure against NV-HAP, the impact of different types of oral care on the
oral microbiome and NV-HAP has not been systematically studied in non-ventilated patients. Before exploring
interventions, a baseline knowledge of how the oral microbiome alters during hospitalization in non-ventilated
patients must be established. The environment influences oral microbiota, thus patients admitted to the
hospital from a nursing home may have a different baseline oral specimen than those admitted from home,
potentially leading to worse outcomes. This prospective, observational study will: (1) Longitudinally explore
changes in the oral microbiome of non-ventilated hospitalized patients; (2) Explore the relationship between
pre-hospital residence (nursing home versus home) and non-ventilated patient’s baseline oral microbiome; and
(3) Explore the relationship between the oral microbiome and NV-HAP development. Study recruitment and
data collection will occur in two progressive care units at Orlando Regional Medical Center. We aim to recruit
70 participants within 72 hours of hospital admission from either a nursing home or home, who are non-
ventilated, and > 65 years of age. Demographic and longitudinal clinical data will be collected from the
electronic medical record (EMR) and/or patients. Pre-hospital residence and NV-HAP data will be recorded
from the EMR. Baseline oral salivary specimens will be obtained at enrollment (within 72 hours of hospital
admission) and days 3, 5, and 7, or immediately before patient discharge. Oral specimens will be taken by the
PI to the University of Central Florida Genomics Cluster laboratory for analysis. Analyses metrics will include
bacterial taxonomy identification, alpha-diversity, and beta-diversity. The proposed training plan will provide the
fellow with an opportunity to work with a multi-disciplinary team to build upon her program of research in non-
ventilated hospitalized patients and ultimately become an independent nurse scientist. This study supports the
NINR’s overarching goals of promoting innovation and developing future nurse scientists. The proposed study
is also highly relevant to the NIH Precision Medicine Initiative by informing clinicians of whether specific oral
microbial colonization and pre-hospital residence place a patient at a greater risk for NV-HAP development,
which will aid in the development of individualized preventive measures. Findings will advance the scientific
knowledge of how the oral microbiome alters during hospitalization, thus working towards the long-term goal of
improving the health and outcomes of non-ventilated hospitalized patients.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Oral Microbes in Hospital-Acquired Pneumonia: Practice and Research Implications.
医院获得性肺炎的口腔微生物:实践和研究意义。
DOI:
10.4037/ccn2022672
发表时间:
2022-06-01
期刊:
Critical care nurse
影响因子:
1.6
作者:
[Rathbun KP, Bourgault AM, Sole ML]
通讯作者:
Sole ML
Exploration of the Oral Microbiome in Non-Ventilated Hospitalized Patients
-
批准号:10285988
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2020
-
负责人:Kimberly P Rathbun
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: